Patented antimicrobial technology
with permanent effects
providing unalterable, odorless and full protection of the treated product.
A team of researchers, academics and hospital clinicians are constantly working on the development of BioShield One applications
The current SARS-CoV-2 (COVID-19) pandemic highlights the exceptional potential
of this technology.
The fight against the proliferation, propagation and transmission,
particularly by hand, of many microorganisms
Safety, hygiene and permanent protection for the end users
is the paramount solution
BioShield One is an innovative antimicrobial patented technology that uses pure treated silver microparticles.
It allows silver microparticles to be gripped directly and permanently into and out of the polymers.
There is no release of the treated silver particles.
Silver has been known for centuries for its antimicrobial properties and for its human innocuity.
BioShield One has enhanced these properties.
All the biocidal properties of silver are used: yeasts, viruses, fungi, etc.
Prevention and fight
against the scourge
of nosocomial infections:
The University of Paris and its Research Department, which is also part of the Materials Institute of the University of Paris, has chosen BioShield One to work jointly on several projects in the field of development of medical devices, with the objective to fight and reduce nosocomial deseases.
Its unit studies the interrelationships that are established between cells and their different environments (natural: extracellular matrix, biofilms, microenvironment, materials … or artificial: surfaces, synthetic materials, biomaterials …)